Vaccine Makers Fall With Covid Therapies in Political Crosshairs

(Bloomberg) -- U.S. vaccine developers tumbled as competition from the U.K. and a focus on Covid-19 plasma treatments curbed investor enthusiasm for the stocks.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.